Compare ARK Genomic Revolution ETF (ARKG) vs Jones Lang LaSalle Inc (JLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Jones Lang LaSalle Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.88, while Jones Lang LaSalle Inc trades at $365.99 (market cap $16.72B). Which is the better fit depends on your goals.
| ARKG | JLL | |
|---|---|---|
Sector | Sector/Thematic | Real Estate |
52-Week High | $44.55 | $373.24 |
52-Week Low | $24.02 | $280.16 |
Market Cap | — | $16.72B |
Enterprise Value | — | $19.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →
